Pfizer is considering selling its hospital drugs unit as it faces pressure from activist investor Starboard Value to divest non-core assets. Reuters exclusively reported this move, highlighting the pharmaceutical company’s strategic decision-making amidst industry shifts. This development underscores Pfizer’s focus on streamlining its operations and responding to investor demands for improved performance.
Full Article
The Smartest S&P 500 ETF to Buy With $500 Right Now
Investing in the stock market can be simplified by mirroring the S&P 500 index, which offers great long-term results without the stress of individual stock performance. For those with a $500 budget, the SPDR Portfolio S&P 500 ETF (SPLG) is an affordable option at $70 per share, compared to pricier alternatives like Vanguard and SPDR ETFs. Explain It To Me Like I'm 5: You can invest in a big group of companies easily by buying...
Read more